Canada markets closed

Astellas Pharma Inc. (ALPMY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10.04+0.07 (+0.70%)
At close: 03:59PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
No. of Analysts0010
Avg. Estimate000.30
Low Estimate000.30
High Estimate000.30
Year Ago EPSN/AN/A0.070.3
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
No. of Analysts1010
Avg. Estimate10.82BN/A10.82BN/A
Low Estimate10.82BN/A10.82BN/A
High Estimate10.82BN/A10.82BN/A
Year Ago Sales11.09BN/A11.09B10.82B
Sales Growth (year/est)-2.40%N/A-2.40%N/A
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
Current Estimate000.30
7 Days Ago000.30
30 Days Ago000.430
60 Days Ago000.430
90 Days Ago000.440
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2025)Next Year (2026)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALPMYIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year328.60%N/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)14.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A